$Chanticleer Holdings (BURG.US)$Mike Pruitt, Chanticleer Holdings CEO stated, “We are pleased that our shareholders have approved all of the proposals included in our recent proxy statement. Importantly, shareholder approval now allows for both us and Sonnet BioTherapeutics, Inc. to move forward with the closing of our proposed merger transaction and the spin-off of Chanticleer’s restaurant business. As we stated in our recent press release, the record date for the share distribution related to the spin-off of the restaurant business has been established as March 26, 2020. The spin-off and merger are expected to close on or around March 31, 2020, subject to satisfaction of certain closing conditions. All shareholders of record at the close of busi